ANI Pharmaceuticals' CFO Sells $285,000 in Stock Following 32% One-Year Return
Stephen P. Carey, CFO of ANI Pharmaceuticals (ANIP), sold 3,313 shares worth $285,000 on July 2, 2026, under a Rule 10b5-1 trading plan. The stock had delivered a one-year total return of 32% as of the transaction date.
Tickers: $ANIP
Topics: Rule 10b5-1 plan SEC filing stock sale